Literature DB >> 18752948

Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.

Daniel K Nomura1, Carolyn S S Hudak, Anna M Ward, James J Burston, Roger S Issa, Karl J Fisher, Mary E Abood, Jenny L Wiley, Aron H Lichtman, John E Casida.   

Abstract

The structure-activity relationships of organophosphorus (OP) and organosulfur compounds were examined in vitro and in vivo as inhibitors of mouse brain monoacylglycerol lipase (MAGL) hydrolysis of 2-arachidonoylglycerol (2-AG) and agonist binding at the CB1 receptor. Several compounds showed exceptional potency toward MAGL activity with IC(50) values of 0.1-10 nM in vitro and high inhibition at 10mg/kg intraperitoneally in mice. We find for the first time that MAGL activity is a major in vivo determinant of 2-AG and arachidonic acid levels not only in brain but also in spleen, lung, and liver. Apparent direct OP inhibition of CB1 agonist binding may be due instead to metabolic stabilization of 2-AG in brain membranes as the actual inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752948      PMCID: PMC2593629          DOI: 10.1016/j.bmcl.2008.08.007

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Modulation of inflammation in brain: a matter of fat.

Authors:  Akhlaq A Farooqui; Lloyd A Horrocks; Tahira Farooqui
Journal:  J Neurochem       Date:  2007-01-25       Impact factor: 5.372

Review 2.  Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.

Authors:  George Kunos; Douglas Osei-Hyiaman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

3.  Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.

Authors:  M E Abood; K E Ditto; M A Noel; V M Showalter; Q Tao
Journal:  Biochem Pharmacol       Date:  1997-01-24       Impact factor: 5.858

Review 4.  Endocannabinoids and the regulation of their levels in health and disease.

Authors:  Vincenzo Di Marzo; Stefania Petrosino
Journal:  Curr Opin Lipidol       Date:  2007-04       Impact factor: 4.776

5.  Each lipase has a unique sensitivity profile for organophosphorus inhibitors.

Authors:  Gary B Quistad; Shannon N Liang; Karl J Fisher; Daniel K Nomura; John E Casida
Journal:  Toxicol Sci       Date:  2006-01-31       Impact factor: 4.849

6.  A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.

Authors:  Jacqueline L Blankman; Gabriel M Simon; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2007-12

Review 7.  Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.

Authors:  Francesco Cipollone; Giancarlo Cicolini; Marco Bucci
Journal:  Pharmacol Ther       Date:  2008-02-02       Impact factor: 12.310

8.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

Review 9.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Authors:  Charles N Serhan; Nan Chiang; Thomas E Van Dyke
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 10.  Modulation of the endocannabinoid system by lipid rafts.

Authors:  Enrico Dainese; Sergio Oddi; Monica Bari; Mauro Maccarrone
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  30 in total

1.  Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.

Authors:  Vincenzo Di Marzo
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

2.  Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.

Authors:  Pretal P Muldoon; Lois S Akinola; Joel E Schlosburg; Aron H Lichtman; Laura J Sim-Selley; Anu Mahadevan; Benjamin F Cravatt; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-05-30       Impact factor: 5.250

3.  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.

Authors:  Jonathan Z Long; Daniel K Nomura; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2009-07-31

Review 4.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

Review 5.  Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

Authors:  Antonio Luchicchi; Marco Pistis
Journal:  Mol Neurobiol       Date:  2012-07-17       Impact factor: 5.590

Review 6.  Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.

Authors:  Rebecca A Kohnz; Daniel K Nomura
Journal:  Chem Soc Rev       Date:  2014-03-28       Impact factor: 54.564

Review 7.  Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platforms.

Authors:  Daniel Medina-Cleghorn; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-09-18

Review 8.  Metabolomic strategies to map functions of metabolic pathways.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-10       Impact factor: 4.310

9.  The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.

Authors:  Jenny L Wilkerson; Sudeshna Ghosh; Mohammed Mustafa; Rehab A Abdullah; Micah J Niphakis; Roberto Cabrera; Rafael L Maldonado; Benjamin F Cravatt; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2016-11-25       Impact factor: 5.250

Review 10.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.